Among the major cancer drivers of differentiated thyroid cancers, B-type Raf kinase (BRAF) mutation exclusively occurred in papillary thyroid cancer (PTC) and PTC-derived anaplastic thyroid cancer (ATC) is associated with low iodine avidity [3]. Here, BRAF is linked to cancer.